Biosimilar Medicines Reading List | Medicines for Europe

From disruption to care for cancer patients 5 September 2022 Biosimilar medicines are biologic medicines that can be used safely…
Biosimilar medicines: competition, sustainability and early*… 30 October 2019 Medicines for Europe welcomes 5th European Commission Stakeholder event on…
Interview: Medicines for Europe Reports on EU Biosimilar… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…
Generic & biosimilar medicines pivotal for safe, effective… 28 November 2019 The European Commission has identified the use of generic and…